Marché du dépistage du cancer du sein – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00009796
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 156
Buy Now

[Rapport de recherche]Le marché du dépistage du cancer du sein devrait atteindre 6 209,25 millions de dollars US d'ici 2027, contre 4 638,63 millions de dollars US en 2019 ; on estime qu'il augmentera à un TCAC de 4,8 % de 2020 à 2027.



Le cancer du sein est le type de cancer le plus courant et le plus répandu chez les femmes ; il se développe dans les tissus mammaires, généralement dans les canaux (tubes qui transportent le lait jusqu'au mamelon) et les lobules (glandes qui produisent le lait). Il peut également se produire dans le tissu adipeux ou le tissu conjonctif fibreux des seins. Le diagnostic précoce du cancer du sein est important car il peut empêcher la condition de devenir critique et assurer un traitement curable réussi. Les méthodes de dépistage pour le diagnostic du cancer du sein comprennent la mammographie, l'imagerie par résonance magnétique (IRM), l'échographie et autres. L'objectif principal du dépistage est de détecter la maladie à son stade le plus précoce et le plus traitable. Les procédures de dépistage identifient les premiers signes de cancer, avant même que les symptômes ne commencent à se manifester.



Marchés régionaux lucratifs du dépistage du cancer du sein

Aperçu du marché



Globally Growing Breast Prévalence du cancer



Le cancer du sein est l'une des principales causes de décès dans le monde et affecte profondément la qualité de vie. Ainsi, il agit comme un fardeau pour la société s'il n'est pas diagnostiqué et traité à temps. Selon les estimations de l'American Cancer Society, le cancer du sein est le type de cancer le plus répandu aux États-Unis, car il a causé une morbidité chez environ 234 087 personnes et entraîné 41 904 décès en 2018. De plus, environ 276 480 nouveaux cas sont attendus dans le pays en 2020. Selon le rapport Globocan 2019, en Allemagne, le nombre total de cas de cancer du sein en 2018 était de 71 888, et la maladie a entraîné environ 19 376 décès cette année-là. De plus, selon le rapport Globocan, en 2018, il y a eu environ 367 900 nouveaux cas de cancer du sein et 97 972 décès dus à la même chose en Chine. En Inde, les ONG, les agences gouvernementales et les organisations caritatives mettent l'accent sur la sensibilisation au cancer du sein au sein de la population pour promouvoir la détection précoce, fournir un module de traitement complet et étendre le soutien à la gestion du cancer du sein. Ces initiatives sont le résultat de la prévalence croissante de ce type de cancer dans le pays. Selon l'estimation du rapport Globocan, en 2018, l'Inde a signalé environ 162 468 nouveaux cas de cancer du sein et 87 090 décès dus à la même chose. Une telle prévalence croissante du cancer du sein dans différentes régions du monde augmente la demande mondiale pour les dispositifs de dépistage pour le même.





Test Type-Based Market Insights



Le marché du dépistage du cancer du sein, par type de produit, est segmenté en tests de marqueurs sanguins, test d'imagerie, test génétique, test d'immunohistochimie. Le segment des tests d'imagerie détenait la plus grande part du marché en 2019, et il devrait également enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Marché mondial du dépistage du cancer du sein, par type de produit - 2018 et 2027



Perspectives basées sur l'utilisateur final



Sur la base de l'utilisateur final, le marché du dépistage du cancer du sein a été segmenté en hôpitaux, centres de diagnostic, instituts de cancérologie et laboratoires de recherche. Le segment des hôpitaux détenait la plus grande part du marché en 2019, tandis que le segment des centres de diagnostic devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Perspectives stratégiques



Produit lancements et approbations est une stratégie couramment adoptée par les entreprises du marché du dépistage du cancer du sein pour étendre leur présence dans le monde et répondre à la demande croissante en élargissant leurs portefeuilles de produits. Ils adoptent également la stratégie d'expansion pour élargir la clientèle à travers le monde, ce qui leur permet également de maintenir leur marque à l'échelle mondiale. Par exemple, en juin 2017, Siemens Healthineers a reçu l'approbation de la Food and Drug Administration (FDA) du produit à savoir syngo.via VB20 qui est susceptible d'être utilisé pour l'imagerie moléculaire (IM) de Siemens Healthineers - une nouvelle version de la visualisation intelligente établie par la société logiciel d'imagerie multimodalité.



Marché du dépistage du cancer du sein – Par type de produit




  • Test de marqueur sanguin

  • Test d'imagerie

  • Test génétique

  • Test d'immunohistochimie


Marché du dépistage du cancer du sein - Par application




  • Centres de diagnostic

  • Hôpitaux

  • Laboratoires de recherche

  • Instituts du cancer


Dépistage du cancer du sein - Par géographie




  • Amérique du Nord

    • États-Unis

    • Canada

    • Mexique



  • Europe

    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste de l'Europe



  • Asie-Pacifique

    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • Reste de l'Asie-Pacifique



  • Moyen-Orient et Afrique

    • Afrique du Sud

    • Arabie saoudite

    • EAU
    • Reste du Moyen-Orient et Afrique



  • Amérique du Sud

    • Brésil

    • Argentine

    • Reste d'Amérique du Sud




Profils des entreprises




  • General Electric Company

  • Siemens Healthineers AG
  • Exact Sciences Corporation

  • Koninklijke Philips NV

  • Hologic, Inc.

  • BD

  • Myriad Genetics, Inc.
  • Oncocyte Corporation

  • Danaher

  • POC Medical Systems


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are breast cancer screening mean?

The diagnosis of breast cancer is done through breast cancer screening methods such as mammography, magnetic resonance imaging (MRI), ultrasound, and others. Screening examinations are tests performed for early diagnosis of the disease. The foremost goal of screening is to detect disease at its earliest and most treatable stage.

What are the driving factors for the breast cancer screening market across the globe?

The growth of the market is attributed to some key driving factors such as increasing number of breast cancer cases, growing geriatric population and rising adoption of technology for screening purpose. However, high cost of screening method and bassinet on global business due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.

What is the regional analysis in terms of breast cancer screening?

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for breast cancer screening mean market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer, growing developments for screening and imaging process by the companies and others.

The List of Companies - Breast Cancer Screening Market

  1. Koninklijke Philips N.V..
  2. HOLOGIC, INC.
  3. BD
  4. MYRIAD GENETICS, INC.
  5. SIEMENS HEALTHCARE GMBH
  6. Exact Sciences Corporation
  7. ONCOCYTE CORPORATION
  8. POC MEDICAL SYSTEMS
  9. Danaher
  10. GENERAL ELECTRIC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports